Jan 16 (Reuters) - Britain's health regulator approved a maximum dose of up to 7.2 miligrams per week of Novo Nordisk's blockbuster weight-loss drug Wegovy for patients with obesity only, it said on Friday.
(Reporting by Yamini Kalia in Bengaluru; Editing by Sonia Cheema)
